Dipesh Khanal | Experimental Methods | Best Researcher Award

Published on by Physicist Particle

Dr. Dipesh Khanal | Experimental Methods | Best Researcher Award

Dr. Dipesh Khanal, The University of Sydney, Australia

Dr. Dipesh Khanal is a Postdoctoral Fellow and Nano-characterisation theme leader at the University of Sydney’s Pharmacy School. He earned his Ph.D. in Pharmaceutics from the same institution in 2018 and holds a Master of Pharmacy from Kathmandu University, Nepal, where he graduated Magna Cum Laude. Dr. Khanal specializes in nano-characterisation, pulmonary formulations, and advanced drug delivery systems. His research is funded by prestigious bodies like the US FDA, and he has been recognized with awards for his contributions to nanoscale toxicology and aerosol drug delivery.

PROFILE

Orcid Profile

Scopus Profile

Educational Details

Dr. Dipesh Khanal is a Postdoctoral Fellow and Nano-characterisation theme leader at the Advanced Drug Delivery Group, Sydney Pharmacy School, The University of Sydney. He holds a Ph.D. in Pharmaceutics from The University of Sydney (2014-2018) and a Master of Pharmacy (Magna Cum Laude) from Kathmandu University, Nepal (2009-2011), where he was the batch topper. He earned his Bachelor of Pharmacy from the same institution in 2006.

Professional Experience

Dr. Khanal has been a postdoctoral fellow since 2018, where he has played a pivotal role in advancing nano-characterisation and biopharmaceutical formulations. His expertise includes particle production techniques like spray drying, lyophilization, and air jet milling. He has developed advanced analytical techniques such as AFM-IR spectroscopy and optical photothermal infrared spectroscopy for nanoparticle characterization. Dr. Khanal has successfully secured competitive funding, including grants from the US FDA, ARC, and NSW funding bodies. He has co-supervised two PhD students and managed high-impact research projects, particularly in pulmonary formulations, aerosol characterization, and bacteriophage tablet formulation.

Research Interest

Dr. Khanal specializes in nano-characterisation, nanotechnology in drug delivery, pulmonary formulations, and the mechanical analysis of nanoparticles. His research explores aerosol delivery systems, nanotoxicity assessment, and the development of analytical methods to characterize drug nanocrystals within liposomes.

Grants and Awards

2023 Provost’s CAPEX Fund: AUD 756,000 for a Multimodal, Correlative, and Multiscale Characterisation Platform.

2022 US FDA Research Support: USD 1.25 million for nanospectroscopy and nano-thermal analysis of drug aerosols.

2019 Sydney Nano Publication Award: For a paper on nanodiamond particles and nanotoxicity assessment.

2018 Nanoscale Horizons Outstanding Paper Award: For nanoscale characterization using AFM-IR spectroscopy.

2017 Award for reducing the use of animals in research via 3D scaffold-free liver models for nanotoxicity studies.

Top Notable Publications

Khanal, D., Cao, Y., Tai, W., & Kim Chan, H. (2024). O-PTIR spectroscopy for characterizing active pharmaceutical ingredient specific particle size distributions of nasal spray suspension products. International Journal of Pharmaceutics, 664, 124653.

Zhang, J., Khanal, D., Chan, H.-K., & Banaszak Holl, M.M. (2024). Nanoscale colocalized thermal and chemical mapping of pharmaceutical powder aerosols. International Journal of Pharmaceutics, 656, 124116.

Cao, Y., Khanal, D., Kim, J., Banaszak Holl, M.M., & Chan, H.-K. (2023). Stability of bacteriophages in organic solvents for formulations. International Journal of Pharmaceutics, 646, 123505.

Wang, Y., Khanal, D., Alreja, A.B., Britton, W.J., & Chan, H.-K. (2023). Bacteriophage endolysin powders for inhaled delivery against pulmonary infections. International Journal of Pharmaceutics, 635, 122679.

Khanal, D., Kim, J., Zhang, J., Holl, M.M.B., & Chan, H.-K. (2023). Optical photothermal infrared spectroscopy for nanochemical analysis of pharmaceutical dry powder aerosols. International Journal of Pharmaceutics, 632, 122563.

Zhang, J., Khanal, D., & Banaszak Holl, M.M. (2023). Applications of AFM-IR for drug delivery vector characterization: infrared, thermal, and mechanical characterization at the nanoscale. Advanced Drug Delivery Reviews, 192, 114646.

Albariqi, A.H., Ke, W.-R., Khanal, D., Drago, J., & Chan, H.-K. (2022). Preparation and characterization of inhalable ivermectin powders as a potential COVID-19 therapy. Journal of Aerosol Medicine and Pulmonary Drug Delivery, 35(5), 239–251.

Global Collaboration and Leadership

He has established successful collaborations with regulatory authorities like the US FDA, academic partners globally, and industries. His role in leading research teams, managing significant projects, and fostering collaborations reflects his leadership and organizational capabilities, which are critical attributes for this award.

Conclusion

Dr. Dipesh Khanal’s profound contributions to nanotechnology, drug delivery systems, and his leadership in pharmaceutical research make him an excellent contender for the Research for Best Researcher Award. His work not only demonstrates scientific innovation but also holds real-world applicability in medicine, regulatory science, and industrial research. His accomplishments align well with the award’s emphasis on research innovation, publication record, and community impact.

 

 

Payam Dibaj | Experimental Methods | Best Researcher Award

Published on by Physicist Particle

Dr. Payam Dibaj | Experimental Methods | Best Researcher Award

Dr. Payam Dubai, Center for Rare Diseases, Germany

Dr. Payam Dibaj, FEBN is a highly qualified physician specializing in neurology. Born on September 20, 1977, in Tehran, he holds German citizenship. Dr. Dibaj is a Fellow of the European Board of Neurology (FEBN) and has extensive experience in clinical practice and research in neurological disorders. His work is recognized for its impact on patient care and the advancement of neurological science.

PROFILE

Scopus Profile

Educational Details

Dr. Payam Dibaj’s educational background is marked by exceptional academic achievement. He completed his General University Entrance Qualification (Abitur) in 1998 with a top grade of 1.0. Following this, he pursued his studies in human medicine at the Georg August University Göttingen, graduating in November 2005 with a state examination grade of 1.0. During his time at Göttingen, Dr. Dibaj also conducted significant research for his dissertation in the Department of Molecular Pharmacology, under the guidance of Prof. Dr. H.-J. Steinfelder. His dissertation, titled “Investigations into the Function of Domains of the Transcription Factor Pax6 with the Help of the GAL4 System,” was awarded Magna cum laude, reflecting the high quality and impact of his research.

Professional Experience:

Dr. Payam Dibaj has made significant contributions to the field of neurology and neurogenetics throughout his career. Since September 2006, he has been a dedicated scientist in the Neurogenetics Department at the Max Planck Institute for Multidisciplinary Natural Sciences in Göttingen, where he focuses on “Axon-Glia Interaction in Neurodegenerative Diseases” under the leadership of Prof. K. A. Nave. His clinical experience includes serving as a Senior Physician in the Neurology Department at the Schildautal Clinics in Seesen from January 2015 to June 2021, where he specialized in neurodegenerative diseases, including the management of complex Parkinson’s cases and overseeing the Empowerment Outpatient Clinic for Parkinson’s and dementia diseases. Dr. Dibaj also worked as a specialist in the MVZ Wolfsburg from March 2018 to July 2021, providing consultation in neurology. Since February 2019, he has been the Medical Coordinator at the Center for Rare Diseases (ZSEG) at the University Medical Center Göttingen (UMG), collaborating with notable experts such as Prof. J. Gärtner, Prof. K. Brockmann, and Prof. B. Wollnik. Additionally, he served as a Senior Physician in the Neurology Department at St. Ansgar-Höxter Hospital from July 2021 to December 2022.

Top Notable Publications

Patient Experiences of Interprofessional Collaboration and Intersectoral Communication in Rare Disease Healthcare in Germany – A Mixed-Methods Study

Authors: Inhestern, L., Otto, R., Brandt, M., Härter, M., Bergelt, C.

Journal: Orphanet Journal of Rare Diseases

Year: 2024

Volume: 19(1)

Page: 197

Citations: 0

Note: Open access

Intracranial Hypotension Due to a Large Thoracic Meningocele

Authors: Dibaj, P., Haji, F., Obermann, M.

Journal: Deutsches Ärzteblatt International

Year: 2023

Volume: 120(11)

Pages: 192

Citations: 0

Note: Open access

Plastic Spinal Motor Circuits in Health and Disease

Authors: Windhorst, U., Dibaj, P.

Journal: Journal of Integrative Neuroscience

Year: 2023

Volume: 22(6)

Page: 167

Citations: 1

Note: Open access

Hemifacial Spasm Through Changes of Cerebrospinal Fluid Pressure in Idiopathic Intracranial Hypertension

Authors: Petersen, G.C., Amirkhizi, M., Brockmann, K., Dibaj, P.

Journal: Baylor University Medical Center Proceedings

Year: 2023

Volume: 36(1)

Pages: 114–115

Citations: 1

Note: Open access

Follow-up of a Case of Dopamine-Mediated Yawning-Fatigue-Syndrome Responsive to Opioids, Successful Desensitization via Graded Activity Treatment

Authors: Dibaj, P., Seeger, D., Gärtner, J., Petzke, F.

Journal: Neurology International

Year: 2021

Volume: 13(1)

Pages: 79–84

Citations: 0

Note: Open access

Modulation of Cognition and Neuronal Plasticity in Gain- and Loss-of-Function Mouse Models of the Schizophrenia Risk Gene Tcf4

Authors: Badowska, D.M., Brzózka, M.M., Kannaiyan, N., Malzahn, D., Rossner, M.J.

Journal: Translational Psychiatry

Year: 2020

Volume: 10(1)

Article: 343

Citations: 12

Note: Open access

Lyme Neuroborreliosis with Long Meningeal Enhancement and Ischemic Stroke

Authors: Dibaj, P., Schnegelsberg, M., Kroger, R.

Journal: European Neurology

Year: 2020

Volume: 83(3)

Pages: 323–324

Citations: 0

Dopamine-Mediated Yawning-Fatigue Syndrome with Specific Recurrent Initiation and Responsiveness to Opioids

Authors: Dibaj, P., Brockmann, K., Gärtner, J.

Journal: JAMA Neurology

Year: 2020

Volume: 77(2)

Pages: 254

Citations: 2

Anillin Facilitates Septin Assembly to Prevent Pathological Outfoldings of Central Nervous System Myelin

Authors: Erwig, M.S., Patzig, J., Steyer, A.M., Nave, K.-A., Werner, H.B.

Journal: eLife

Year: 2019

Volume: 8

Article: e43888

Citations: 41

Test Your Knowledge | Testen Sie Ihr Fachwissen

Authors: Dibaj, P., Kröger, R., Kallenberg, K., Obermann, M., Harun, A.

Journal: Aktuelle Neurologie

Year: 2018

Volume: 45(3)

Pages: 212–214